We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pfizer Inc | NYSE:PFE | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.19 | 0.75% | 25.45 | 25.54 | 25.20 | 25.33 | 46,479,621 | 00:58:17 |
By Jared S. Hopkins
Pfizer Inc. said Tuesday it could have a coronavirus vaccine ready for use on an emergency basis in the fall if it proves to work safely in testing.
Testing of the vaccine, which has already started in Germany, could start in the U.S. as early as next week if health regulators sign off, Pfizer Chief Executive Albert Bourla said in an interview. Results from the study could come as early as next month, Mr. Bourla said.
Pfizer would need to do more testing to make sure the vaccine works safely. If all testing proves successful, Pfizer could start distributing the vaccine on an emergency basis in the fall and receive approval for widespread distribution by year's end, Mr. Bourla said.
"This is a crisis right now, and a solution is desperately needed by all, " Mr. Bourla said.
Write to Jared S. Hopkins at jared.hopkins@wsj.com
(END) Dow Jones Newswires
April 28, 2020 13:29 ET (17:29 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions